Search

Andalib Ft Lodhi

Examiner (ID: 12467, Phone: (571)270-1759 , Office: P/2162 )

Most Active Art Unit
2162
Art Unit(s)
2163, 2169, 2154, 2162
Total Applications
390
Issued Applications
276
Pending Applications
2
Abandoned Applications
112

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18162088 [patent_doc_number] => 20230028680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => EXPANSION OF NATURAL KILLER CELLS AND ILC3 CELLS WITH NOVEL AROMATIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/309449 [patent_app_country] => US [patent_app_date] => 2019-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75844 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309449 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/309449
EXPANSION OF NATURAL KILLER CELLS AND ILC3 CELLS WITH NOVEL AROMATIC COMPOUNDS Nov 28, 2019 Abandoned
Array ( [id] => 17367395 [patent_doc_number] => 20220022447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => EX VIVO ORGAN TREATMENT WITH PEG-PHOSPHOLIPID MOLECULES [patent_app_type] => utility [patent_app_number] => 17/297112 [patent_app_country] => US [patent_app_date] => 2019-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16012 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17297112 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/297112
EX VIVO ORGAN TREATMENT WITH PEG-PHOSPHOLIPID MOLECULES Nov 28, 2019 Pending
Array ( [id] => 17314821 [patent_doc_number] => 20210403869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => Osteoblasts derived from oral neuroectodermal stem cells and their use in jaw repair [patent_app_type] => utility [patent_app_number] => 17/291661 [patent_app_country] => US [patent_app_date] => 2019-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3856 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291661 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/291661
Osteoblasts derived from oral neuroectodermal stem cells and their use in jaw repair Nov 27, 2019 Abandoned
Array ( [id] => 17383906 [patent_doc_number] => 20220031758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => USE OF ANIMAL ORIGINATED CORNEA MEMBRANE PRODUCTS IN TREATMENT OF EYE AND OUT OF EYE WOUNDS [patent_app_type] => utility [patent_app_number] => 17/298784 [patent_app_country] => US [patent_app_date] => 2019-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2139 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17298784 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/298784
USE OF ANIMAL ORIGINATED CORNEA MEMBRANE PRODUCTS IN TREATMENT OF EYE AND OUT OF EYE WOUNDS Nov 27, 2019 Abandoned
Array ( [id] => 17299837 [patent_doc_number] => 20210395676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => CARRIER FOR CELL CULTURE COMPRISING MICROCAPSULES CONTAINING NATURAL OIL [patent_app_type] => utility [patent_app_number] => 17/283503 [patent_app_country] => US [patent_app_date] => 2019-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6787 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283503 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/283503
CARRIER FOR CELL CULTURE COMPRISING MICROCAPSULES CONTAINING NATURAL OIL Nov 11, 2019 Pending
Array ( [id] => 17370284 [patent_doc_number] => 20220025336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => METHOD FOR PRODUCING INSULIN-PRODUCING CELLS, AND COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/288636 [patent_app_country] => US [patent_app_date] => 2019-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6766 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288636 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/288636
METHOD FOR PRODUCING INSULIN-PRODUCING CELLS, AND COMPOSITION Nov 10, 2019 Pending
Array ( [id] => 17299823 [patent_doc_number] => 20210395662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => Cell Culture Device [patent_app_type] => utility [patent_app_number] => 17/292245 [patent_app_country] => US [patent_app_date] => 2019-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5501 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292245 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/292245
Cell Culture Device Nov 7, 2019 Pending
Array ( [id] => 17256802 [patent_doc_number] => 20210369787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => ADIPOCYTE MEDIATED DELIVERY OF ANTICANCER THERAPEUTICS [patent_app_type] => utility [patent_app_number] => 17/290470 [patent_app_country] => US [patent_app_date] => 2019-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16541 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17290470 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/290470
ADIPOCYTE MEDIATED DELIVERY OF ANTICANCER THERAPEUTICS Oct 31, 2019 Abandoned
Array ( [id] => 17273047 [patent_doc_number] => 20210379245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => Soluble Extracellular Matrix Composition and Method for Intravascular Delivery [patent_app_type] => utility [patent_app_number] => 17/286534 [patent_app_country] => US [patent_app_date] => 2019-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8650 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17286534 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/286534
Soluble Extracellular Matrix Composition and Method for Intravascular Delivery Oct 24, 2019 Pending
Array ( [id] => 15527687 [patent_doc_number] => 20200056149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-20 [patent_title] => READY-TO-USE CRYOPRESERVED CELLS [patent_app_type] => utility [patent_app_number] => 16/664182 [patent_app_country] => US [patent_app_date] => 2019-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14207 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16664182 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/664182
READY-TO-USE CRYOPRESERVED CELLS Oct 24, 2019 Pending
Array ( [id] => 17214782 [patent_doc_number] => 20210348119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => COMPOSITIONS AND METHODS FOR CELL CULTURE [patent_app_type] => utility [patent_app_number] => 17/284215 [patent_app_country] => US [patent_app_date] => 2019-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21625 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284215 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/284215
COMPOSITIONS AND METHODS FOR CELL CULTURE Oct 10, 2019 Pending
Array ( [id] => 17198799 [patent_doc_number] => 20210338893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => BIOLOGIC TISSUE PROCESSING DEVICE [patent_app_type] => utility [patent_app_number] => 17/283263 [patent_app_country] => US [patent_app_date] => 2019-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10170 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283263 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/283263
BIOLOGIC TISSUE PROCESSING DEVICE Oct 9, 2019 Abandoned
Array ( [id] => 17385924 [patent_doc_number] => 20220033776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => METHODS OF MAKING PLATELETS COMPRISING MODIFIED RECEPTORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/280415 [patent_app_country] => US [patent_app_date] => 2019-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17803 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17280415 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/280415
METHODS OF MAKING PLATELETS COMPRISING MODIFIED RECEPTORS AND USES THEREOF Sep 30, 2019 Pending
Array ( [id] => 17299842 [patent_doc_number] => 20210395681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => CULTURE MEDIUM FOR GROWTH OF NEURAL STEM CELLS [patent_app_type] => utility [patent_app_number] => 17/283955 [patent_app_country] => US [patent_app_date] => 2019-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4795 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283955 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/283955
CULTURE MEDIUM FOR GROWTH OF NEURAL STEM CELLS Sep 26, 2019 Abandoned
Array ( [id] => 17315913 [patent_doc_number] => 20210404961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => METHODS AND USES FOR DETERMINING OSTEOGENIC POTENTIAL OF IN VITRO DIFFERENTIATED CELLS [patent_app_type] => utility [patent_app_number] => 17/279294 [patent_app_country] => US [patent_app_date] => 2019-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33747 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17279294 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/279294
METHODS AND USES FOR DETERMINING OSTEOGENIC POTENTIAL OF IN VITRO DIFFERENTIATED CELLS Sep 24, 2019 Abandoned
Array ( [id] => 17299847 [patent_doc_number] => 20210395686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => METHODS FOR DIFFERENTIATING MESENCHYMAL STEM CELLS [patent_app_type] => utility [patent_app_number] => 17/278938 [patent_app_country] => US [patent_app_date] => 2019-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30260 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17278938 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/278938
METHODS FOR DIFFERENTIATING MESENCHYMAL STEM CELLS Sep 24, 2019 Abandoned
Array ( [id] => 17228615 [patent_doc_number] => 20210355171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => ADENO-ASSOCIATED VIRUS HAVING A VARIANT CAPSID PROTEIN, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/284673 [patent_app_country] => US [patent_app_date] => 2019-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6091 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284673 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/284673
ADENO-ASSOCIATED VIRUS HAVING A VARIANT CAPSID PROTEIN, AND USE THEREOF Sep 23, 2019 Pending
Array ( [id] => 17426033 [patent_doc_number] => 20220053741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => Complement Factor H Gene Knockout Rat as a Model of C3 Glomerulopathy [patent_app_type] => utility [patent_app_number] => 17/275096 [patent_app_country] => US [patent_app_date] => 2019-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29431 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -53 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275096 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/275096
Complement factor H gene knockout rat as a model of C3 glomerulopathy Sep 11, 2019 Issued
Array ( [id] => 16948397 [patent_doc_number] => 20210207088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => COMPOSITION AND METHOD FOR PRESERVING OR CULTURING OCULAR CELLS [patent_app_type] => utility [patent_app_number] => 17/269278 [patent_app_country] => US [patent_app_date] => 2019-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269278 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/269278
COMPOSITION AND METHOD FOR PRESERVING OR CULTURING OCULAR CELLS Aug 29, 2019 Abandoned
Array ( [id] => 17154148 [patent_doc_number] => 20210315199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => CRYOPRESERVATION MEDIUM FOR UMBILICAL CORD MSCS DERIVED FROM WHARTON'S JELLY [patent_app_type] => utility [patent_app_number] => 17/267545 [patent_app_country] => US [patent_app_date] => 2019-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3260 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267545 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/267545
CRYOPRESERVATION MEDIUM FOR UMBILICAL CORD MSCS DERIVED FROM WHARTON'S JELLY Aug 11, 2019 Abandoned
Menu